GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Eli Lilly and Co (BSP:LILY34) » Definitions » Cyclically Adjusted Book per Share

Eli Lilly and Co (BSP:LILY34) Cyclically Adjusted Book per Share : R$2.37 (As of Mar. 2025)


View and export this data going back to 2013. Start your Free Trial

What is Eli Lilly and Co Cyclically Adjusted Book per Share?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

Eli Lilly and Co's adjusted book value per share for the three months ended in Mar. 2025 was R$3.371. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is R$2.37 for the trailing ten years ended in Mar. 2025.

During the past 12 months, Eli Lilly and Co's average Cyclically Adjusted Book Growth Rate was -0.60% per year. During the past 3 years, the average Cyclically Adjusted Book Growth Rate was -0.80% per year. During the past 5 years, the average Cyclically Adjusted Book Growth Rate was -0.70% per year. During the past 10 years, the average Cyclically Adjusted Book Growth Rate was -0.30% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Book Growth Rate using Cyclically Adjusted Book per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Book Growth Rate of Eli Lilly and Co was 8.80% per year. The lowest was -2.00% per year. And the median was 3.95% per year.

As of today (2025-06-02), Eli Lilly and Co's current stock price is R$141.42. Eli Lilly and Co's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2025 was R$2.37. Eli Lilly and Co's Cyclically Adjusted PB Ratio of today is 59.67.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of Eli Lilly and Co was 77.55. The lowest was 5.24. And the median was 11.62.


Eli Lilly and Co Cyclically Adjusted Book per Share Historical Data

The historical data trend for Eli Lilly and Co's Cyclically Adjusted Book per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Eli Lilly and Co Cyclically Adjusted Book per Share Chart

Eli Lilly and Co Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Cyclically Adjusted Book per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 2.12 2.32 2.24 1.99 2.53

Eli Lilly and Co Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Cyclically Adjusted Book per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2.09 2.31 2.23 2.53 2.37

Competitive Comparison of Eli Lilly and Co's Cyclically Adjusted Book per Share

For the Drug Manufacturers - General subindustry, Eli Lilly and Co's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Eli Lilly and Co's Cyclically Adjusted PB Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Eli Lilly and Co's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Eli Lilly and Co's Cyclically Adjusted PB Ratio falls into.


;
;

Eli Lilly and Co Cyclically Adjusted Book per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

What is Cyclically Adjusted Book per Share? How do we calculate Cyclically Adjusted Book per Share?

Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Book per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the book value per share from 2001 through 2010.

We adjusted the 2001 book value per share data with the total inflation from 2001 through 2010 to the equivalent book value in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's book value is $1 a share in 2001, then the 2001's equivalent book value in 2010 is $1.4 a share. If Wal-Mart's book value is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 book value in 2010 is $1.35. So on and so forth, you get the equivalent book value per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Eli Lilly and Co's adjusted Book Value per Share data for the three months ended in Mar. 2025 was:

Adj_Book= Book Value per Share /CPI of Mar. 2025 (Change)*Current CPI (Mar. 2025)
=3.371/134.9266*134.9266
=3.371

Current CPI (Mar. 2025) = 134.9266.

Eli Lilly and Co Quarterly Data

Book Value per Share CPI Adj_Book
201506 1.373 100.684 1.840
201509 1.787 100.392 2.402
201512 1.705 99.792 2.305
201603 1.676 100.470 2.251
201606 1.513 101.688 2.008
201609 1.531 101.861 2.028
201612 1.423 101.863 1.885
201703 1.326 102.862 1.739
201706 1.407 103.349 1.837
201709 1.412 104.136 1.830
201712 1.157 104.011 1.501
201803 1.453 105.290 1.862
201806 1.352 106.317 1.716
201809 1.678 106.507 2.126
201812 1.204 105.998 1.533
201903 0.327 107.251 0.411
201906 0.370 108.070 0.462
201909 0.484 108.329 0.603
201912 0.372 108.420 0.463
202003 0.524 108.902 0.649
202006 0.740 108.767 0.918
202009 0.908 109.815 1.116
202012 1.011 109.897 1.241
202103 1.351 111.754 1.631
202106 1.129 114.631 1.329
202109 1.427 115.734 1.664
202112 1.775 117.630 2.036
202203 1.628 121.301 1.811
202206 1.513 125.017 1.633
202209 1.852 125.227 1.995
202212 1.960 125.222 2.112
202303 2.047 127.348 2.169
202306 1.886 128.729 1.977
202309 1.946 129.860 2.022
202312 1.956 129.419 2.039
202403 2.362 131.776 2.418
202406 2.704 132.554 2.752
202409 2.921 133.029 2.963
202412 3.216 133.157 3.259
202503 3.371 134.927 3.371

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.


Eli Lilly and Co  (BSP:LILY34) Cyclically Adjusted Book per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Book per Share may underestimate the company's equity. Cyclically Adjusted PB Ratio can seem to be too high even the actual PB Ratio is low.

For the Cyclically Adjusted PB Ratio, the book value of the past 10 years are inflation-adjusted and averaged. The result is used for P/B calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PB Ratio is also called CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

Eli Lilly and Co's Cyclically Adjusted PB Ratio of today is calculated as

Cyclically Adjusted PB Ratio=Share Price/Cyclically Adjusted Book per Share
=141.42/2.37
=59.67

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of Eli Lilly and Co was 77.55. The lowest was 5.24. And the median was 11.62.


Be Aware

Cyclically Adjusted PB Ratio works better for cyclical companies. It gives you a better idea on the company's real book value.


Eli Lilly and Co Cyclically Adjusted Book per Share Related Terms

Thank you for viewing the detailed overview of Eli Lilly and Co's Cyclically Adjusted Book per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Eli Lilly and Co Business Description

Industry
Address
Lilly Corporate Center, Indianapolis, IN, USA, 46285
Eli Lilly is a drug firm with a focus on neuroscience, cardiometabolic, cancer, and immunology. Lilly's key products include Verzenio for cancer; Mounjaro, Zepbound, Jardiance, Trulicity, Humalog, and Humulin for cardiometabolic; and Taltz and Olumiant for immunology.

Eli Lilly and Co Headlines

No Headlines